A clear guide to the transition most NZ women aren't warned about: the biology, the timeline, and what it means for how you feel.
By The element³ Team
10 min read
What Perimenopause Actually Is
Perimenopause is the transitional phase before menopause: the years during which the ovaries gradually wind down their hormonal output, oestrogen and progesterone begin to fluctuate and decline, and the body adjusts to a new hormonal baseline. It ends when a woman hasn't had a period for 12 consecutive months, which is defined as menopause. Everything that precedes that point is perimenopause.
The distinction matters because 'menopause' is often used colloquially to describe the entire transition, including everything that happens before and after. Perimenopause is a distinct and often lengthy stage, during which the hormonal picture is characterised by fluctuation and unpredictability rather than simple decline. Understanding this is key to understanding why symptoms can feel variable, confusing, and hard to pin down.
When Does Perimenopause Start? The NZ Timeline
The average age of menopause in New Zealand is 51. Working backwards, perimenopause typically begins 4 -10 years before that, placing the onset for most NZ women between 42 and 48. Early perimenopause before 40 affects roughly 5% of women.
What most women aren't told is that the hormonal changes that seed perimenopause begin considerably earlier. Progesterone levels start declining from the mid-30s, often before any other noticeable change. This is the physiological beginning of the transition, even if the symptoms are subtle enough to go unrecognised.
The Full Perimenopause Symptom Picture, and the Biology Behind Each One
There are upward of 30 recognised symptoms associated with perimenopause. The table below maps the most clinically significant ones to the hormonal mechanisms that drive them. Understanding the mechanism is useful for two reasons: it makes the symptom picture coherent rather than arbitrary, and it points toward what kinds of support are most relevant.
A few points worth drawing out from the table. Hot flushes and night sweats: the symptoms most commonly associated with menopause in popular culture, are driven primarily by oestrogen-related changes to thermoregulation and tend to be more prominent in mid-to-late perimenopause and early postmenopause. The symptoms that appear earlier and are more frequently missed are the neurological and mood-related ones: sleep disruption, anxiety, brain fog, fatigue, and mood changes. These are progesterone- and cortisol-mediated, and they often precede vasomotor symptoms by several years.
The Symptoms Most Commonly Misattributed, and Why That Matters
Four symptoms in particular are routinely explained away rather than connected to perimenopause, and the consequences of that misattribution are significant, because the wrong explanation leads to the wrong response.
Anxiety
Perimenopause-related anxiety is driven by two converging mechanisms: progesterone decline removes the primary neurological buffer against the stress response (progesterone metabolises into allopregnanolone, which acts on GABA receptors), and cortisol dysregulation creates a nervous system that's chronically slightly elevated. The result is anxiety that feels qualitatively different from event-driven anxiety, more like a constant background hum, a heightened startle response, a tendency to catastrophise, or a sense of unease that appears without clear cause.
Because this anxiety doesn't have an obvious psychological source, it's often attributed to life circumstances, overwork, or a general inability to cope. It's sometimes treated with antidepressants before the hormonal connection is investigated. For women in their early 40s with no prior anxiety history experiencing this pattern, perimenopausal hormonal changes should be one of the first considerations.
Brain fog
Brain fog: the word-finding difficulty, the lost train of thought, the inability to hold complex information in working memory that many women describe as alarming, is tied to fluctuating estradiol levels rather than simple decline. When estradiol swings unpredictably, the hippocampus and prefrontal cortex enter periods of reduced function. Critically, this fluctuates: some days feel sharp, others do not. That variability is actually a diagnostic signal. It suggests hormonal driving rather than a neurodegenerative process.
Brain imaging research by Dr Lisa Mosconi at Weill Cornell Medicine has documented measurable changes in brain energy metabolism and connectivity beginning in perimenopause, correlating with the cognitive symptoms women report.¹ This isn't imagined. It's a real, observable neurological change, and one that resolves or significantly improves in most women after the transition.
Fatigue
Perimenopausal fatigue has multiple contributing mechanisms: disrupted sleep architecture that reduces restorative deep sleep, cortisol dysregulation that flattens the morning energy curve, declining mitochondrial efficiency associated with hormonal change, and in some cases iron deficiency from heavier perimenopausal bleeding. The result is fatigue that's not proportional to activity level or sleep quantity, which is what distinguishes it from ordinary tiredness and makes it confusing.
Afternoon energy crashes are particularly characteristic. Oestrogen supports brain glucose metabolism, and when levels fluctuate, cognitive and physical energy in the 2–4pm window becomes less reliable. Women who previously had no trouble sustaining performance through the afternoon often notice this first as a perimenopausal change.
Sleep disruption
Waking consistently between 2am and 4am, alert, unable to return to sleep, is one of the most specific patterns of early perimenopause. It's driven primarily by cortisol dysregulation (the early morning cortisol spike that progressive progesterone decline fails to buffer) rather than hot flushes. Many women experiencing this pattern have no vasomotor symptoms at all.
The mechanisms behind perimenopausal sleep disruption are covered in depth in our article: Why Am I Waking Up at 3am? The Perimenopause Sleep Guide for NZ Women.
How Perimenopause Is Diagnosed in NZ, and Why Blood Tests Are Often Unhelpful
In New Zealand, perimenopause is a clinical diagnosis. It's made based on symptoms and age, not laboratory results. This is the formal position of the NZ Menopause Society and is consistent with international clinical guidelines.²
The reason blood tests are unreliable during perimenopause is specific to the biology of the transition. Hormone levels, oestrogen, progesterone, FSH, fluctuate dramatically from day to day, and sometimes hour to hour. A single serum sample captures a snapshot of a moving target. A result that falls within the normal range on Tuesday may be significantly outside it on Thursday. A normal FSH result doesn't rule out the perimenopausal transition. This isn't a limitation of the test. It's a fundamental feature of perimenopausal endocrinology.
If your GP is unfamiliar with perimenopause or dismisses symptoms without investigation, a second opinion is reasonable. The NZ Menopause Society maintains a directory of practitioners with specific experience in menopause management.
What Supports the Transition: Lifestyle, Nutrition, and When to Talk to Your GP
Menopausal hormone therapy (MHT)
For women with significant perimenopausal symptoms, MHT, particularly body-identical transdermal oestrogen with micronised progesterone, is the most evidence-supported intervention available. The safety profile of modern body-identical MHT is substantially more favourable than the older synthetic formulations that generated concern in the early 2000s, and NZ access has improved considerably. MHT is a conversation worth having with your GP if symptoms are meaningfully affecting quality of life.
Resistance training and weight-bearing exercise
Oestrogen has a protective role in maintaining muscle mass, bone density, and metabolic function. As it declines, these become more vulnerable. Resistance training is the single most evidence-supported lifestyle intervention for mitigating this, maintaining muscle mass, supporting insulin sensitivity, and improving mood and sleep quality via the same neurobiological pathways that perimenopause disrupts. Thirty minutes of resistance training, three times a week, is a realistic and meaningful target.
Blood sugar regulation
Oestrogen supports insulin sensitivity. Perimenopausal oestrogen fluctuation compromises it. The result: blood sugar regulation becomes less reliable during this transition, contributing to energy crashes, mood instability, the 3am waking pattern, and weight changes around the abdomen. Eating adequate protein at each meal (supporting satiety and preventing glucose spikes), limiting refined carbohydrates, and avoiding large evening meals are practical measures with meaningful effects on perimenopausal symptom severity.
Targeted nutritional supplementation
Supplements work by supporting the physiological systems that perimenopausal hormonal changes disrupt, primarily the GABA, cortisol, melatonin, and mitochondrial energy systems. The most relevant compounds for the perimenopausal transition:
- Magnesium citrate: supports GABA signalling, cortisol regulation, and sleep architecture. Directly addresses the progesterone-GABA gap that drives anxiety and sleep disruption.
- Sensoril® Ashwagandha: root-and-leaf extract with evidence for HPA axis regulation and the early-morning cortisol dysregulation underlying the 3am waking pattern.
- L-Theanine: supports alpha brain wave activity and GABA production. Addresses the persistent mild anxiety and cognitive background noise characteristic of early perimenopause.
- B vitamins (B6 as P-5-P: B12, folate), support neurotransmitter synthesis (serotonin, dopamine, GABA), energy metabolism, and cognitive function. Deficiency compounds perimenopausal mood and cognitive symptoms.
- Vitamin D3: supports bone density, immune function, mood, and the regulation of oestrogen receptor sensitivity. NZ women, particularly in winter and lower light regions, are commonly deficient.
How element³ Is Formulated for the Perimenopausal Transition
element³'s product range is designed around the biology of the day, morning and evening, and maps directly to the symptom pattern of perimenopause. Each formula targets a distinct biological window and the hormonal mechanisms most active in it.
The protocol design reflects element³'s core principle: every ingredient has a specific role, and its timing is determined by when it's most biologically useful. For women in perimenopause, that timing alignment matters.
Two products. One protocol. Designed around your biology.
→ Shop the full element³ range
→ Start with REST for sleep support
→ Start with RISE for energy and cognition
Your Questions
How do I know if I'm in perimenopause?
Perimenopause is diagnosed by symptoms and age, not blood tests. If you're in your 40s, or late 30s, and experiencing sleep disruption, anxiety, mood changes, fatigue, brain fog, or cycle changes without another clear explanation, these are meaningful signals. A conversation with your GP is the appropriate next step. You don't need to wait until your periods become irregular, and you don't need a positive blood test.
How long does perimenopause last?
The average duration is 4–10 years, though this varies considerably between women. Some experience a shorter, more intense transition; others have a gradual change over a decade. The NZ average age of menopause is 51, which places the average onset of perimenopause between 42 and 48, though as the timeline table above shows, the hormonal groundwork begins considerably earlier.
Can perimenopause cause anxiety?
Yes, directly, through two converging mechanisms. Progesterone decline reduces the neurological buffer that normally moderates the stress response. Cortisol dysregulation produces a chronic low-level elevation of the nervous system. The result is anxiety that can feel qualitatively different from situation-driven anxiety: more persistent, less proportional to circumstances, and often new in a woman who hasn't had anxiety previously. If you're in your 40s and experiencing this pattern, perimenopause is a clinically relevant consideration.
My periods are still regular. Can I still be in perimenopause?
Yes. Regular periods don't rule out early perimenopause. Progesterone begins to decline before the menstrual cycle becomes irregular, and the sleep, mood, and cognitive symptoms of early perimenopause can be present for years before periods change. The relationship between cycle regularity and perimenopausal status is commonly misunderstood, including sometimes by healthcare providers.
What's the difference between perimenopause and menopause?
Menopause is technically a single point in time: the moment 12 consecutive months have passed since your last period. Everything before that: the years of hormonal fluctuation and transition, is perimenopause. Everything after is postmenopause. In common usage, 'menopause' is often used to refer to the entire transition, but perimenopause is the stage where most of the symptomatic experience occurs.
Is it safe to take supplements during perimenopause?
Most nutritional supplements used to support the perimenopausal transition, magnesium, ashwagandha, L-theanine, B vitamins, vitamin D, have well-established safety profiles in healthy women. Some herbal compounds (including black cohosh and vitex) have specific contraindications or interactions with medications and should be discussed with a healthcare provider. If you're on any prescription medication or have a diagnosed health condition, check with your GP or pharmacist before starting a new supplement regimen.
References
1. Mosconi L, et al. (2021). Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Scientific Reports, 11, 10867. doi:10.1038/s41598-021-90084-y
2. New Zealand Menopause Society. (2024). Perimenopause, diagnosis and management. Menopause.org.nz
3. Kravitz HM, et al. (2003). Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause, 10(1), 19–28.
4. Prior JC. (2005). Perimenopause: the complex endocrinology of the menopausal transition. Endocrine Reviews, 19(4), 397–428.
5. Santoro N, Epperson CN, Mathews SB. (2015). Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America, 44(3), 497–515.
6. Australasian Menopause Society. (2023). Premature ovarian insufficiency and early menopause. Menopause.org.au
This article is for educational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider before starting any new supplement, particularly if you're pregnant, breastfeeding, or taking prescription medication.
